Vestal Point Capital’s Viking Therapeutics VKTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-75,000	Closed	-$6.15M	–	77
2024 Q1	$6.15M	Buy	+75,000	New	+$6.15M	0.51%	38